TalkMed Group Past Earnings Performance

Past criteria checks 2/6

TalkMed Group's earnings have been declining at an average annual rate of -1%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 3.7% per year. TalkMed Group's return on equity is 33.6%, and it has net margins of 35.8%.

Key information

-1.0%

Earnings growth rate

-1.2%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate3.7%
Return on equity33.6%
Net Margin35.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Mar 01
TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Recent updates

TalkMed Group (SGX:5G3) Seems To Use Debt Quite Sensibly

Sep 26
TalkMed Group (SGX:5G3) Seems To Use Debt Quite Sensibly

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Apr 08
Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Mar 01
TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Revenue & Expenses Breakdown

How TalkMed Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SGX:5G3 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24792810
31 Mar 24813010
31 Dec 23843210
30 Sep 23833110
30 Jun 23823110
31 Mar 23793110
31 Dec 22773110
30 Sep 22702810
30 Jun 22642610
31 Mar 22632610
31 Dec 21612510
30 Sep 21622510
30 Jun 21602310
31 Mar 21612310
31 Dec 20622320
30 Sep 20672720
30 Jun 20713120
31 Mar 20743410
31 Dec 19763600
30 Sep 19733410
30 Jun 19713310
31 Mar 19663120
31 Dec 18612920
30 Sep 18582830
30 Jun 18552720
31 Mar 18572920
31 Dec 17613220
30 Sep 17653420
30 Jun 17683520
31 Mar 17693720
31 Dec 16693720
30 Sep 16683710
30 Jun 16673610
31 Mar 16663610
31 Dec 15663710
30 Sep 15653810
30 Jun 15654010
31 Mar 15654010
31 Dec 14633910
30 Sep 14613210
30 Jun 14593110
31 Mar 14583000
31 Dec 13562800

Quality Earnings: 5G3 has high quality earnings.

Growing Profit Margin: 5G3's current net profit margins (35.8%) are lower than last year (37.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 5G3's earnings have declined by 1% per year over the past 5 years.

Accelerating Growth: 5G3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 5G3 had negative earnings growth (-8.4%) over the past year, making it difficult to compare to the Healthcare industry average (-35.5%).


Return on Equity

High ROE: 5G3's Return on Equity (33.6%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies